ERTS Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
ERTS Wealth Advisors's PFE Position: Q3 2024 in Review
ERTS Wealth Advisors sold out of Pfizer (PFE) in Q3 2024, closing a stake of 7,463 shares — an estimated $209K sold.
ERTS Wealth Advisors first reported a position in PFE in Q4 2018 and held it in 23 quarters. The position peaked at $1.06M in Q4 2021. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.
- ERTS Wealth Advisors reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
- ERTS Wealth Advisors sold 7,463 Pfizer shares in Q3 2024, an estimated $209K.
- ERTS Wealth Advisors first reported a position in Pfizer in Q4 2018 and held it in 23 quarters.
- ERTS Wealth Advisors's Pfizer position peaked at $1.06M in Q4 2021.
- 2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.
Based on ERTS Wealth Advisors's 13F filing for Q3 2024, filed 17 Oct 2024.